{"id":6934,"date":"2025-03-12T01:15:08","date_gmt":"2025-03-12T05:15:08","guid":{"rendered":"https:\/\/www.ast-inc.com\/?p=6628"},"modified":"2025-03-12T01:15:08","modified_gmt":"2025-03-12T05:15:08","slug":"our-new-atmp-fill-finish-production-line-for-interphex-2025-press-release","status":"publish","type":"post","link":"https:\/\/www.ast-inc.com\/news-and-events\/our-new-atmp-fill-finish-production-line-for-interphex-2025-press-release\/","title":{"rendered":"AST Brings New ATMP Fill-Finish Production Line to INTERPHEX 2025"},"content":{"rendered":"\n
<\/div>\n\n\n\n

AST to introduce its fully automatic isolated GENiSYS C in addition to new glove testing and digital twin solutions during the premier global pharmaceutical event at Javits Center, NYC.<\/em><\/p>\n\n\n\n

AST\u2019s exhibit at INTERPHEX 2025 represents a comprehensive, forward-looking aseptic processing product and service advancement. The fully automatic GENiSYS C is a fourth-generation fill-finish system designed to meet and exceed regulations, including the latest Annex 1. The automated, multi-format filling and closing system is designed to process commercial and custom nested vials, syringes, and cartridges on a compact, no-touch production line. The system exhibited at INTERPHEX will be placed with Ascend Advanced Therapies, a specialist adeno-associated virus (AAV) development partner, at their state-of-the-art manufacturing facility in Alachua, Florida.<\/p>\n\n\n\n

The isolated GENiSYS C at INTERPHEX 2025 will include AST\u2019s Atmos\u2122 isolator technology, featuring best-in-class functionality and efficacy, as part of an end-to-end turnkey solution offered from AST and backed by a localized model of supply and service. Alongside the advanced fill-finish system, AST will be offering demonstrations of their new glove testing system, Shield\u2122 GIT, and their new digital twin solution.<\/p>\n\n\n\n

\u201cWe\u2019re thrilled to once again be showcasing our latest innovations at INTERPHEX 2025,\u201d commented AST President and CEO Joe Hoff. \u201cThe industry continues to innovate towards advanced, integrated technologies that improve quality, processing, and time to patient for advanced therapeutics. The latest isolated GENiSYS C featured alongside our new wireless glove testing system and digital twin solution is clear progress towards that goal. These offerings further demonstrate AST\u2019s commitment to being a full-service provider of American-made turnkey solutions for drug manufacturing.\u201d  <\/p>\n\n\n\n

Additionally, AST will be commencing its 60th anniversary year with a Diamond Celebration featuring giveaways and special events throughout the week of INTERPHEX.<\/p>\n\n\n\n

Innovation Highlights<\/strong><\/h2>\n\n\n\n

Digital Twin:<\/em><\/p>\n\n\n\n

AST\u2019s digital twin solution is rooted in the innovative cross-section of the physical, digital, and data spaces provided by digital twin technology, and offers exciting applications for the production of liquid pharmaceuticals at every stage of drug development. AST\u2019s in-booth demonstration will include:<\/p>\n\n\n\n